Legal Representation
Attorney
DAVID DONAHUE
USPTO Deadlines
Application History
34 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 28, 2025 | ETOP | T | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | Loading... |
| Aug 14, 2025 | OP.I | T | OPPOSITION INSTITUTED NO. 999999 | Loading... |
| Apr 21, 2025 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED | Loading... |
| Apr 1, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 1, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 26, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 5, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 20, 2024 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Feb 12, 2024 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Aug 5, 2023 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Jan 24, 2023 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| May 18, 2022 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Oct 6, 2021 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Aug 4, 2021 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Aug 4, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Aug 4, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Aug 4, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Aug 4, 2021 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Jun 2, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 22, 2021 | GRML | O | CORRESPONDENCE E-MAILED | Loading... |
| Mar 22, 2021 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Mar 22, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 22, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 22, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 28, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 28, 2020 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 28, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 16, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 16, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 16, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 8, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 30, 2020 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Jun 29, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 9, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of diseases of the digestive system, gynecological diseases and skin diseases; veterinary preparations for the treatment of diseases of the digestive system, gynecological diseases and skin diseases; medical preparations for hygiene, namely, medical preparations for woman's intimate hygiene; dietetic substances adapted for medical use, namely, food for medically restricted diets; baby food; and food supplements; ferments for pharmaceutical or veterinary purposes; milk ferments for pharmaceutical purposes; pharmaceutical preparations for the treatment of disorders caused by bacteria; pharmaceutical preparations for the prevention of disorders caused by bacteria; probiotic preparations for medical use to help maintain a natural balance of flora in the digestive system; probiotic preparations comprised of bacterial formulations for medical purposes; bacterial and bacteriological preparations for medical or veterinary purposes; pharmaceuticals in the nature of immunotherapeutic agents for bacterial infections; pharmaceuticals in the nature of compositions based on lactic bacteria for use as drugs in the treatment of bacterial infections and for use as dietetic food adapted for medical use and dietary supplements
Additional Information
Design Mark
THE MARK CONSISTS OF A SHIELD IN THE COLOR BLUE DISPLAYING HORIZONTAL PARALLEL LINES WITHIN. THE LINES APPEAR IN THE COLOR LIGHT BLUE. AT THE RIGHT OF THE SHIELD, THE WORD VSL#3 APPEARS IN THE COLOR BLUE IN A STYLIZED FONT, WITH THE WORDS THE LIVING SHIELD APPEARING IN STYLIZED FONT TYPE AND DISPLAYED IN BLUE.
Color Claim
The color(s) blue is/are claimed as a feature of the mark.
Classification
International Classes
005